Alexánderson E, Ricalde A, Estradas J, Alexánderson EG, Meave A

Language: Spanish
References: 31
Page: 23-28
PDF size: 68.00 Kb.

ABSTRACT

Coronary artery disease (CAD) represents the principal cause of morbidity and mortality in our environment. Positron emission tomography (PET) is a new technique in our country that allows the assessment of myocardial perfusion and the absolute quantification of the coronary blood flow (CBF) through the utilization of radiotracers using the same criteria employed in conventional nuclear cardiology. CBF normal values have been determined in other populations around the world. No studies in our country assessing in a non-invasive way the CBF have been published before. The quantification of CBF in healthy population is important to establish a standard measure and determine through it, the effects of the many diseases that change the coronary blood flow. The quantification of the CBF, the calculation of coronary blood flow reserve (CFR) and the endothelium dependent vasodilatation index (EDVI) through PET is possible performing three different acquisition stages: rest, cold pressor test (CPT) and pharmacologic stress using Ammonia as radiotracer. The aim of this study was to evaluate the CBF, the CFR and the EDVI in healthy Mexican volunteers. Results: Global basal CBF was 0.34 (±0.09) mL/g/min, during CPT increased to 0.55 (±0.17) mL/g/min and during the stress increased to 1.18 (±0.25). CFR was 3.5 (±0.65) and EDVI was 1.55 (±0.33). Conclusions: CFR and EDVI values obtained in Mexican healthy population correlates very well with those reported in the literature. This values represents a reference to further research that use this technology.

REFERENCES

1. Porcentaje de defunciones generales por sexo y principales causas, 1990-2002. Instituto Nacional de Estadística Geográfica e Informática. México. http://www.inegi.gob.mx/est/contenidos/espanol/tematicos/mediano/med.asp?t=mpob45&c=3222

2. Muzik O, Beanlands RS, Hutchins GD, Manager TJ, Nguyen N, Schwaiger M: Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993; 34: 83-91.

3. Alexanderson E, Kerik N, Umsek FS, Fermon SS: Principios y aplicaciones de la tomografía por emisión de positrones (PET) en la cardiología. PET en México: una realidad. INCICH 2002: 72, num2: 157-164.

4. Sorenson J A, Phelps ME: Nuclear medicine tomography: systems and devices. En: Physics in nuclear medicine. 2nd Ed. Philadelphia W.B. Saunders Co., 1987: p434-435.

5. Shelbert HR: Principles of positron emission tomography: En: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, eds. Cardiac Imaging. Philadelphia: WB Saunders Company, 1991: 1140-1270.

6. De Silva R, Camici PG: The role of positron emission tomography in the investigation of coronary circulatory function in man. Cardiovasc Res 1994; 28: 1595-1612.

7. Di Carli M F, Tobes MC, et al: Effects of cardiac sympathetic innervation of coronary blood flow. NEJM, 1997. 336: 1208-1215.

8. Prvulovich EM, Bomanji JB (1998): Fortnightly review: The role of nuclear medicine in clinical investigation. BMJ 316: 1140-1146.

9. Sawada S, Muzik O, Beanlnads R, Wolfe E, Hutchings G, Schwaiger M: Interobserver and inter study variability of myocardial blood flow an flow-reserve measurmentes with nitrogen-13-ammonia labele positron emission tomography. J Nucl Med 1995; 2: 4133-22.

10. Zeiher AM, Drexler H, Wollschlager H, Just H: Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984-92.

11. Kirkeeide RL, Gould KL, Parsel L: Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated functional measure of stenosis severity reflecting all its geometric dimensions. J Am Coll Cardiol 1986; 7: 103-13.

12. Graves J, Poston L: Beta – adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and mitric oxide. Br J Pharmacol 1993; 108: 631-7.

13. Jones CJH, DeFily DV, Patterson JL, Chilian WM: Endothelium dependent relaxation compets with a-1 and a-2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation 1993; 87:1264-74.

14. Kichuk MR, Seyedi N, Zhang X: Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996; 94: 44-51.

15. Camici PG, Gropler RJ, Jones T: The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996; 17: 25-34.

16. Bergmann SR, Fox KAA, Rand AL: Quantification of regional myocardial blood flow in vivo with H215O. Circulation 1984; 70: 724-733.

17. Krivokapi ch J, Smith GT, Huang SC: Nitrogen-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989; 80: 1328-1337.

18. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE: Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15: 1032-1042.

19. Araujo LI, Lammertsma AA, Rhodes CG: Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991; 83: 875-885.

20. Gould KL, Kirkeeide RL, Buchi M: Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990; 15: 459-74.

21. Uren NG, Melin JA, De Bruyne B: Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994; 330: 1782-1788.

22. De Bruyne B, Baudhuin T, Melin JA : Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation 1994; 89: 1013-22.

23. Pijls NHJ, Van Gelder B, Van der Voort P: Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-93.

24. Nitzche Egbert U, Choi Young, Czerin Johannes: Noninvasive quantification of myocardial blood flow in humans. Circulation 1996; 93: 2000-2006.

25. Camici PG: Positron Emission Tomography and myocardial imaging. Heart 2000; 83: 475-480.

26. Camici PG, Gropler RJ, Jones T: The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases. Eur Heart J 1996; 17: 25-34.

27. Diamond G, Forrester J: Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 1979; 300: 1350-1358.

28. Ritchie JL, Bateman TM, Bonow RO: Guidelines for clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology. Circulation 1995; 91: 1278-1303.

29. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DP: Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1592-606.

30. Schelbert HR: Positron Emission Tomography of the Heart: Methodology, findings in the normal and the disease heart and clinical applications. En: Phelps ME. PET Molecular Imaging and its Biological Applications. Ed. Springer. New York, 2004: 389-508.

31. Choi Y, Huang SC, Hawkins RA, Kim JY, Kim BT, Hoh CK: Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med 1999;40:1045-55